Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	benzodiazepine receptor binding	RIMBP3 RIMBP3C RIMBP3B	1.53e-06	5	108	3	GO:0030156
GeneOntologyCellularComponent	nuclear body	EPOR HDAC4 HIPK2 FANCL RAD54L2 CMYA5 TRIP12 BRD2 BRCA1 RBM27 FASTK ATF7IP CELF3 CHD5 TRIM8 ZFHX3 SDCBP2	6.19e-06	903	112	17	GO:0016604
GeneOntologyCellularComponent	nuclear speck	EPOR HDAC4 RAD54L2 CMYA5 TRIP12 BRD2 RBM27 FASTK CHD5 SDCBP2	1.09e-04	431	112	10	GO:0016607
GeneOntologyCellularComponent	transcription regulator complex	HDAC4 ASCL5 HLF HIPK2 POU2AF1 GTF3C5 MLXIPL ATF7IP CHD5 ZFHX3 MED23	3.59e-04	596	112	11	GO:0005667
GeneOntologyCellularComponent	manchette	RIMBP3 RIMBP3C RIMBP3B	4.45e-04	28	112	3	GO:0002177
Domain	FN3	EPOR MYLK SPEG CMYA5 RIMBP3 ATF7IP RIMBP3C IGSF9B RIMBP3B	2.15e-06	199	107	9	PS50853
Domain	FN3_dom	EPOR MYLK SPEG CMYA5 RIMBP3 ATF7IP RIMBP3C IGSF9B RIMBP3B	3.22e-06	209	107	9	IPR003961
Domain	FN3	EPOR MYLK SPEG CMYA5 RIMBP3C IGSF9B RIMBP3B	9.46e-05	185	107	7	SM00060
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	SHROOM3 HDAC4 TEX14 RAD54L2 POM121C WNK1 TRIP12 CIC TMEM92 TULP4 CHD5 RNF38 IGSF9B SDCBP2 NEURL4 CRTC2	7.28e-13	430	112	16	35044719
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SEMA6C SHROOM3 CTC1 SPEG PER1 MED13L POM121C WNK1 CIC ZNF503 RADIL BRD2 TULP4 CHD5 TTLL4 CSPG4 DHX34 RBM38	1.61e-08	1105	112	18	35748872
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SHROOM3 HDAC4 WNK1 NCKAP5L TRIP12 CIC MLXIPL RADIL NF1 ANKRD17 HELZ USP54 PPIP5K2 AKAP1 CRTC2	1.20e-07	861	112	15	36931259
Pubmed	RIM-BP3 is a manchette-associated protein essential for spermiogenesis.	RIMBP3 RIMBP3C RIMBP3B	1.30e-07	4	112	3	19091768
Pubmed	Structure and evolution of RIM-BP genes: identification of a novel family member.	RIMBP3 RIMBP3C RIMBP3B	3.24e-07	5	112	3	17855024
Pubmed	A human MAP kinase interactome.	HDAC4 HIPK2 SYNPO POM121C WNK1 NCKAP5L CIC CSN2 ATF7IP ANKRD17 HELZ	5.23e-07	486	112	11	20936779
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SEMA6C SHROOM3 SYNPO RBM27 CHD5 TTLL4 ANKRD17 PPIP5K2 MED23 OGA DHX34	1.20e-06	529	112	11	14621295
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PER1 TRAPPC8 POM121C WNK1 PARP4 RADIL TULP4 TXNDC16 POM121B NEURL4	4.66e-06	493	112	10	15368895
Pubmed	Transcriptomic analysis of CIC and ATXN1L reveal a functional relationship exploited by cancer.	ATXN1L CIC	1.03e-05	2	112	2	30093628
Pubmed	Germline mutations in NF1 and BRCA1 in a family with neurofibromatosis type 1 and early-onset breast cancer.	NF1 BRCA1	1.03e-05	2	112	2	23624750
Pubmed	ATXN1L, CIC, and ETS Transcription Factors Modulate Sensitivity to MAPK Pathway Inhibition.	ATXN1L CIC	1.03e-05	2	112	2	28178529
Pubmed	The murine homolog of the human breast and ovarian cancer susceptibility gene Brca1 maps to mouse chromosome 11D.	NF1 BRCA1	1.03e-05	2	112	2	8566965
Pubmed	14-3-3 proteins sequester a pool of soluble TRIM32 ubiquitin ligase to repress autoubiquitylation and cytoplasmic body formation.	HDAC4 SPEG WNK1 CRTC2	1.04e-05	42	112	4	23444366
Pubmed	Integrative characterization of germ cell-specific genes from mouse spermatocyte UniGene library.	RIMBP3 RIMBP3C RIMBP3B	1.15e-05	14	112	3	17662146
Pubmed	Human transcription factor protein interaction networks.	HIPK2 RAD54L2 POM121C ATXN1L CIC ZNF503 BRD2 BRCA1 RBM27 ATF7IP CHD5 ANKRD17 HELZ ZFHX3 USP54 RAI2	1.40e-05	1429	112	16	35140242
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	SHROOM3 HDAC4 WNK1 NCKAP5L RADIL NF1 HELZ USP54 CRTC2	1.48e-05	446	112	9	24255178
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	HDAC4 POM121C CIC ZNF503 PARP4 RBM27 ANKRD17 HELZ CRTC2	1.80e-05	457	112	9	32344865
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	TRAPPC8 TRIP12 BRD2 CHD5 ZFHX3	2.16e-05	103	112	5	32744500
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	RAD54L2 WNK1 ATXN1L SSPOP CIC RADIL BRCA1 CELF3 USP54 RAI2	2.84e-05	608	112	10	16713569
Pubmed	POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation.	POM121C POM121B	3.08e-05	3	112	2	30802453
Pubmed	C5a-C5aR1 induces endoplasmic reticulum stress to accelerate vascular calcification via PERK-eIF2α-ATF4-CREB3L1 pathway.	OPRPN C5	3.08e-05	3	112	2	37603848
Pubmed	Attenuation of IgG immune complex-induced acute lung injury by silencing C5aR in lung epithelial cells.	OPRPN C5	3.08e-05	3	112	2	19620403
Pubmed	Nucleoporin POM121 signals TFEB-mediated autophagy via activation of SIGMAR1/sigma-1 receptor chaperone by pridopidine.	POM121C POM121B	3.08e-05	3	112	2	35507432
Pubmed	Effects of C5a and Receptor CD88 on Glutamate and N-Methyl-D-Aspartic Acid Receptor Expression in the Mouse Model of Optic Neuromyelitis.	OPRPN C5	3.08e-05	3	112	2	35509858
Pubmed	Complement C5a promotes antigen cross-presentation by Peyer's patch monocyte-derived dendritic cells and drives a protective CD8+ T cell response.	OPRPN C5	3.08e-05	3	112	2	33852847
Pubmed	Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis.	OPRPN C5	3.08e-05	3	112	2	34971753
Pubmed	TRIM25 promotes Capicua degradation independently of ERK in the absence of ATXN1L.	ATXN1L CIC	3.08e-05	3	112	2	33115448
Pubmed	Neurofibromatosis with male breast cancer--risk factor or co-incidence? Report of two rare cases.	NF1 BRCA1	3.08e-05	3	112	2	25267367
Pubmed	C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis.	OPRPN C5	3.08e-05	3	112	2	19073822
Pubmed	C5a/C5aR pathway is essential for up-regulating SphK1 expression through p38-MAPK activation in acute liver failure.	OPRPN C5	3.08e-05	3	112	2	28028363
Pubmed	Complement factor C5a induces atherosclerotic plaque disruptions.	OPRPN C5	3.08e-05	3	112	2	25124749
Pubmed	Impaired mobilization of hematopoietic stem/progenitor cells in C5-deficient mice supports the pivotal involvement of innate immunity in this process and reveals novel promobilization effects of granulocytes.	OPRPN C5	3.08e-05	3	112	2	19657368
Pubmed	Respiratory Syncytial Virus Exacerbates OVA-mediated asthma in mice through C5a-C5aR regulating CD4+T cells Immune Responses.	OPRPN C5	3.08e-05	3	112	2	29123203
Pubmed	C5a/CD88 signaling alters blood-brain barrier integrity in lupus through nuclear factor-κB.	OPRPN C5	3.08e-05	3	112	2	21929539
Pubmed	C5a-C5AR1 axis as a potential trigger of the rupture of intracranial aneurysms.	OPRPN C5	3.08e-05	3	112	2	38326494
Pubmed	Partial loss of ataxin-1 function contributes to transcriptional dysregulation in spinocerebellar ataxia type 1 pathogenesis.	ATXN1L CIC	3.08e-05	3	112	2	20628574
Pubmed	Complement induction in spinal cord microglia results in anaphylatoxin C5a-mediated pain hypersensitivity.	OPRPN C5	3.08e-05	3	112	2	17687047
Pubmed	Signaling of the Complement Cleavage Product Anaphylatoxin C5a Through C5aR (CD88) Contributes to Pharmacological Hematopoietic Stem Cell Mobilization.	OPRPN C5	3.08e-05	3	112	2	28918528
Pubmed	Experimental Malaria in Pregnancy Induces Neurocognitive Injury in Uninfected Offspring via a C5a-C5a Receptor Dependent Pathway.	OPRPN C5	3.08e-05	3	112	2	26402732
Pubmed	Requisite role for complement C5 and the C5a receptor in granulomatous response to mycobacterial glycolipid trehalose 6,6'-dimycolate.	OPRPN C5	3.08e-05	3	112	2	16101818
Pubmed	C5a-C5aR1 Axis Activation Drives Envenomation Immunopathology by the Snake Naja annulifera.	OPRPN C5	3.08e-05	3	112	2	33936074
Pubmed	Dichotomous ovarian cancer-initiating potential of Pax8+ cells revealed by a mouse genetic mosaic model.	NF1 BRCA1	3.08e-05	3	112	2	37207276
Pubmed	C5aR activation in the absence of C5a: A new disease mechanism of autoimmune hemolytic anemia in mice.	OPRPN C5	3.08e-05	3	112	2	29277896
Pubmed	The C5a/C5aR1 Axis Contributes to the Pathogenesis of Acute Cystitis Through Enhancement of Adhesion and Colonization of Uropathogenic E. coli.	OPRPN C5	3.08e-05	3	112	2	35433513
Pubmed	Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression.	OPRPN C5	3.08e-05	3	112	2	23028051
Pubmed	C5 deficiency and C5a or C5aR blockade protects against cerebral malaria.	OPRPN C5	3.08e-05	3	112	2	18426986
Pubmed	WNK1 promotes renal tumor progression by activating TRPC6-NFAT pathway.	TRPC6 WNK1	3.08e-05	3	112	2	31022353
Pubmed	Complement C5a inhibition reduces atherosclerosis in ApoE-/- mice.	OPRPN C5	6.14e-05	4	112	2	21490292
Pubmed	C5L2 is required for C5a-triggered receptor internalization and ERK signaling.	OPRPN C5	6.14e-05	4	112	2	24631530
Pubmed	C5a/C5aR pathway accelerates renal ischemia-reperfusion injury by downregulating PGRN expression.	OPRPN C5	6.14e-05	4	112	2	29031143
Pubmed	RNA interferences targeting the Fanconi anemia/BRCA pathway upstream genes reverse cisplatin resistance in drug-resistant lung cancer cells.	FANCL BRCA1	6.14e-05	4	112	2	26385482
Pubmed	C5 inhibition prevents renal failure in a mouse model of lethal C3 glomerulopathy.	OPRPN C5	6.14e-05	4	112	2	28139294
Pubmed	Two distinct human POM121 genes: requirement for the formation of nuclear pore complexes.	POM121C POM121B	6.14e-05	4	112	2	17900573
Pubmed	The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues.	BRCA1 CSN2	6.14e-05	4	112	2	7550308
Pubmed	Genetic mapping of opioid binding protein gene(s) to mouse chromosome 9.	EPOR ICAM1	6.14e-05	4	112	2	8439730
Pubmed	Functional roles for C5a receptors in sepsis.	OPRPN C5	6.14e-05	4	112	2	18454156
Pubmed	Complement dependency of cardiomyocyte release of mediators during sepsis.	OPRPN C5	6.14e-05	4	112	2	21478262
Pubmed	The C5a/C5aR2 axis promotes renal inflammation and tissue damage.	OPRPN C5	6.14e-05	4	112	2	32191644
Pubmed	Intracellular complement (complosome) is expressed in hematopoietic stem/progenitor cells (HSPCs) and regulates cell trafficking, metabolism and proliferation in an intracrine Nlrp3 inflammasome-dependent manner.	OPRPN C5	6.14e-05	4	112	2	37055506
Pubmed	Complement 5a Enhances Hepatic Metastases of Colon Cancer via Monocyte Chemoattractant Protein-1-mediated Inflammatory Cell Infiltration.	OPRPN C5	6.14e-05	4	112	2	25739439
Pubmed	Complement C5a Receptor 1 Exacerbates the Pathophysiology of N. meningitidis Sepsis and Is a Potential Target for Disease Treatment.	OPRPN C5	6.14e-05	4	112	2	29362231
Pubmed	A new role of the complement system: C3 provides protection in a mouse model of lung infection with intracellular Chlamydia psittaci.	OPRPN C5	6.14e-05	4	112	2	23189195
Pubmed	O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver.	MLXIPL OGA	6.14e-05	4	112	2	21471514
Pubmed	Tumor necrosis factor-alpha enhances neutrophil adhesiveness: induction of vascular cell adhesion molecule-1 via activation of Akt and CaM kinase II and modifications of histone acetyltransferase and histone deacetylase 4 in human tracheal smooth muscle cells.	HDAC4 ICAM1	6.14e-05	4	112	2	18227124
Pubmed	Airway hyper-reactivity mediated by B-1 cell immunoglobulin M antibody generating complement C5a at 1 day post-immunization in a murine hapten model of non-atopic asthma.	OPRPN C5	6.14e-05	4	112	2	15379984
Pubmed	C5a receptor signaling prevents folate deficiency-induced neural tube defects in mice.	OPRPN C5	6.14e-05	4	112	2	23420882
Pubmed	Expressions of C5a and its receptor CD88 after spinal cord injury in C3-deficient mice.	OPRPN C5	6.14e-05	4	112	2	23033813
Pubmed	Role of the C5a-C5a receptor axis in the inflammatory responses of the lungs after experimental polytrauma and hemorrhagic shock.	OPRPN C5	6.14e-05	4	112	2	33495506
Pubmed	Intracellular complement C5a/C5aR1 stabilizes β-catenin to promote colorectal tumorigenesis.	OPRPN C5	6.14e-05	4	112	2	35649359
Pubmed	NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma.	NF1 CSPG4	6.14e-05	4	112	2	23318450
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	PER1 POM121C NCKAP5L BRD2 BRCA1 CHD5 ANKRD17 HELZ ZFHX3 SIGLEC1 USP54 DHX34 CDH16	6.43e-05	1116	112	13	31753913
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	SGSH ICAM1 GATB SYNPO ACVR2B CUBN WDR3 NF1 BRD2 N6AMT1 CSPG4 SLC49A4 HELZ SDCBP2	7.23e-05	1293	112	14	15342556
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	POM121C TRIP12 WDR3 NF1 RBM27 ANKRD17 USP54 MED23	9.30e-05	440	112	8	34244565
Pubmed	Ataxin-1 regulates B cell function and the severity of autoimmune experimental encephalomyelitis.	ATXN1L CIC	1.02e-04	5	112	2	32878998
Pubmed	C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a.	OPRPN C5	1.02e-04	5	112	2	17322907
Pubmed	Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disorders.	EPOR THPO	1.02e-04	5	112	2	15572213
Pubmed	Drusen complement components C3a and C5a promote choroidal neovascularization.	OPRPN C5	1.02e-04	5	112	2	16452172
Pubmed	A novel role of complement in retinal degeneration.	OPRPN C5	1.02e-04	5	112	2	23074214
Pubmed	Complement-induced activation of MAPKs and Akt during sepsis: role in cardiac dysfunction.	OPRPN C5	1.02e-04	5	112	2	28572445
Pubmed	Complement activation triggers metalloproteinases release inducing cervical remodeling and preterm birth in mice.	OPRPN C5	1.02e-04	5	112	2	21801872
Pubmed	Maea expressed by macrophages, but not erythroblasts, maintains postnatal murine bone marrow erythroblastic islands.	EPOR SIGLEC1	1.02e-04	5	112	2	30674470
Pubmed	53BP1-shieldin-dependent DSB processing in BRCA1-deficient cells requires CST-Polα-primase fill-in synthesis.	CTC1 BRCA1	1.02e-04	5	112	2	35027730
Pubmed	ATF-2 controls transcription of Maspin and GADD45 alpha genes independently from p53 to suppress mammary tumors.	NF1 BRCA1	1.02e-04	5	112	2	17700520
Pubmed	Disruption of the C5a receptor gene increases resistance to acute Gram-negative bacteremia and endotoxic shock: opposing roles of C3a and C5a.	OPRPN C5	1.02e-04	5	112	2	18063050
Pubmed	TRIP12 and UBR5 suppress spreading of chromatin ubiquitylation at damaged chromosomes.	TRIP12 BRCA1	1.02e-04	5	112	2	22884692
Pubmed	ATXN1-CIC Complex Is the Primary Driver of Cerebellar Pathology in Spinocerebellar Ataxia Type 1 through a Gain-of-Function Mechanism.	ATXN1L CIC	1.02e-04	5	112	2	29526553
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	CTC1 FANCL RAD54L2 MED13L GTF3C5 BRCA1 RECQL4 RHNO1	1.14e-04	453	112	8	29656893
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	SPEG TULP4 RBM27 CHD5 TXNDC16	1.42e-04	153	112	5	10718198
Pubmed	Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections.	OPRPN C5	1.53e-04	6	112	2	31274379
Pubmed	Cytokinesis failure in RhoA-deficient mouse erythroblasts involves actomyosin and midbody dysregulation and triggers p53 activation.	EPOR MYLK	1.53e-04	6	112	2	26228485
Pubmed	Complement inhibition and statins prevent fetal brain cortical abnormalities in a mouse model of preterm birth.	OPRPN C5	1.53e-04	6	112	2	24184716
Pubmed	High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease.	NF1 BRCA1	1.53e-04	6	112	2	28608929
Pubmed	Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma.	HDAC4 BRD2	1.53e-04	6	112	2	24229708
Pubmed	IVIG immunotherapy protects against synaptic dysfunction in Alzheimer's disease through complement anaphylatoxin C5a-mediated AMPA-CREB-C/EBP signaling pathway.	OPRPN C5	1.53e-04	6	112	2	23911420
Pubmed	Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response.	OPRPN C5	1.53e-04	6	112	2	25888260
Pubmed	Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis.	OPRPN C5	1.53e-04	6	112	2	18567839
Pubmed	C5a regulates NKT and NK cell functions in sepsis.	OPRPN C5	1.53e-04	6	112	2	22058413
Pubmed	A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis.	OPRPN C5	1.53e-04	6	112	2	28288993
Pubmed	Complement C5a Induces Renal Injury in Diabetic Kidney Disease by Disrupting Mitochondrial Metabolic Agility.	OPRPN C5	1.53e-04	6	112	2	31624141
Pubmed	Tet2- and Tet3- Mediated Cytosine Hydroxymethylation in Six2 Progenitor Cells in Mice Is Critical for Nephron Progenitor Differentiation and Nephron Endowment.	ICAM1 SYNPO CDH16	1.65e-04	33	112	3	36522157
Interaction	TOP3B interactions	SEMA6C SHROOM3 HDAC4 CTC1 SPEG PER1 MED13L POM121C WNK1 CIC ZNF503 RADIL BRD2 TULP4 FASTK CHD5 TTLL4 CSPG4 ANKRD17 HELZ OGA DHX34 ADAMTSL4 RBM38	8.42e-07	1470	109	24	int:TOP3B
Interaction	F12 interactions	PER1 POM121C NF1 RPUSD3 RECQL4 HELZ	3.78e-06	77	109	6	int:F12
Interaction	CTBP1 interactions	HDAC4 HIPK2 FANCL NCKAP5L ATXN1L CIC BRCA1 RECQL4 HELZ MED23 RAI2	1.27e-05	406	109	11	int:CTBP1
Interaction	ERG interactions	HIPK2 RAD54L2 ATXN1L TRIP12 CIC BRD2 ATF7IP TRIM8	2.89e-05	223	109	8	int:ERG
Interaction	TBR1 interactions	ATXN1L CIC ZNF503 BRD2 RECQL4 ZFHX3	3.44e-05	113	109	6	int:TBR1
Interaction	B4GALT2 interactions	PER1 POM121C NACC2 RECQL4 DCHS1 HELZ	4.61e-05	119	109	6	int:B4GALT2
Cytoband	10q22.2	SAMD8 ZNF503 USP54	1.41e-04	41	112	3	10q22.2
Cytoband	22q11.21	RIMBP3 RIMBP3C RIMBP3B CCDC188	1.64e-04	111	112	4	22q11.21
Cytoband	17q22	HLF TEX14 AKAP1	1.74e-04	44	112	3	17q22
Cytoband	19p13.3-p13.2	EPOR ICAM1	5.27e-04	14	112	2	19p13.3-p13.2
Cytoband	Ensembl 112 genes in cytogenetic band chr17q22	HLF TEX14 AKAP1	1.33e-03	88	112	3	chr17q22
GeneFamily	Fibronectin type III domain containing	EPOR MYLK CMYA5 ATF7IP IGSF9B	3.39e-04	160	68	5	555
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma\|TCGA-Brain / Sample_Type by Project: Shred V9	HDAC4 SAMD8 HIPK2 FAM168A TRIM8 USP54 OGA	3.31e-07	177	112	7	e8ab340b20cd41554c3841fe980e078e878af35f
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 NLGN1 TEX14 C5 USP54 AKAP1	3.57e-07	179	112	7	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	droplet-Kidney-nan-18m-Epithelial-kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAPN9 NPBWR1 MYLK SPEG SYNPO CSPG4 ZFHX3	4.98e-07	188	112	7	d1a4cd4db95d8d32b79156290f7867f32824cc87
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 UNC13D NLGN1 C5 USP54	9.65e-07	130	112	6	6434d9106ccb38786dad36fab80163dfc07b6eb7
ToppCell	3'_v3-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages\|lymph-node_spleen / Manually curated celltypes from each tissue	BNC2 ICAM1 ACVR2B TTLL4 SLC49A4 MED23	5.77e-06	177	112	6	52c2ba74a8605260a2623e7d151286e504ac4d19
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 NLGN1 C5 USP54 AKAP1	6.35e-06	180	112	6	b798a3fa2dd15b68aa4267f665559527043dcc07
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 NLGN1 C5 USP54 AKAP1	6.77e-06	182	112	6	17ed11a7ea366dd3106400511d5e628d3f1a9c3e
ToppCell	LPS_only-Epithelial_alveolar-AT_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 NLGN1 C5 USP54 AKAP1	6.98e-06	183	112	6	e972432dd4d1bd31bb0982f4df3061e5e152658f
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 NLGN1 C5 USP54 AKAP1	7.20e-06	184	112	6	d0c212a8fbaad24597a84018442b25c61c17ea58
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 NLGN1 C5 USP54 AKAP1	7.20e-06	184	112	6	ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 NLGN1 C5 USP54 AKAP1	7.66e-06	186	112	6	e83718fabb057100835d3357df407f283d23fe16
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 UNC13D NLGN1 C5 USP54	7.90e-06	187	112	6	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 NLGN1 C5 USP54 AKAP1	8.14e-06	188	112	6	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	droplet-Kidney-nan-21m-Epithelial-Stroma____kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK SPEG TRPC6 SYNPO RIMBP3 CSPG4	8.65e-06	190	112	6	e04f47705851563515b6a66a2634cf7a574f7bda
ToppCell	droplet-Kidney-nan-3m-Epithelial-kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK SPEG TRPC6 SYNPO CSPG4 ZFHX3	9.18e-06	192	112	6	3617d2bc7e33d981f3ec349e9962d8d4bd822fbd
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 SHROOM3 NLGN1 CUBN MED13L ANKRD17	9.18e-06	192	112	6	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK SPEG TRPC6 SYNPO CSPG4 ZFHX3	9.74e-06	194	112	6	80be44e9ddd9f6ddd9dff7cba0eb457431204c2d
ToppCell	11.5-Distal-Mesenchymal-Airway_Smooth_Muscle\|Distal / Age, Tissue, Lineage and Cell class	MYLK SPEG HIPK2 ZFHX3 RAI2 RBM38	1.03e-05	196	112	6	05530fe7a5681c2f39b95016cd22ef99d6ac0430
ToppCell	Skin-Mesangial\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	MYLK SPEG SYNPO SSPOP TTLL4 ALG10	1.13e-05	199	112	6	bcb78838a91cc7828680fb413fbacdb091c5fac0
ToppCell	11.5-Airway-Mesenchymal-Airway_Smooth_Muscle\|Airway / Age, Tissue, Lineage and Cell class	MYLK SPEG HIPK2 ZFHX3 RAI2 RBM38	1.13e-05	199	112	6	1a8c77d241bd817a195e1532fd25f51358cb1ff1
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	SPEG ACVR2B CSPG4 TRIM8 DCHS1	3.64e-05	148	112	5	065177aaa63c0441d312260b43ecdac78c84ad03
ToppCell	LPS_only-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 NLGN1 C5 USP54	4.26e-05	153	112	5	e7a074ea8232bacf924be78a244a8507c7e1ebc8
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CTC1 SPEG TRPC6 GATB RADIL	4.82e-05	157	112	5	f086753b51860e23f1275bd75e8802d2a7d7b70a
ToppCell	Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MYLK SPEG TRPC6 CSPG4 RAI2	5.12e-05	159	112	5	7cda111bb98f1241989e49d490bdf51a712ea589
ToppCell	3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ONECUT2 UGT3A1 SSPOP MLXIPL RBM27	6.65e-05	168	112	5	4e2e4c88ada772e9ba6e72c9ae3a05c063e93318
ToppCell	3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ONECUT2 UGT3A1 SSPOP MLXIPL RBM27	6.65e-05	168	112	5	ee4dab089adef2f47a9d39d91934523331a8b81c
ToppCell	facs-Lung-Endomucin-3m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPOR TRPC6 B4GALNT2 AKAP1 ADAMTSL4	6.83e-05	169	112	5	2d23b4cee060f8adddc430c1c10d4e25205b4af6
ToppCell	facs-Lung-Endomucin-3m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPOR TRPC6 B4GALNT2 AKAP1 ADAMTSL4	6.83e-05	169	112	5	ecaf08e8e0b54d1c97a02bc1f65409fd43d68227
ToppCell	facs-Lung-Endomucin-3m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPOR TRPC6 B4GALNT2 AKAP1 ADAMTSL4	6.83e-05	169	112	5	ad6af6609acf158cb79e45ee7ca9af332be3c40c
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPOR SPEG TRPC6 CSPG4 TPBG	7.63e-05	173	112	5	3059325901b1e5e12a1a91183f14267288b2f600
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYLK SPEG NLGN1 ZFHX3 IGSF9B	7.63e-05	173	112	5	cb6389536195443633adb06e5f1b7483530773d1
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPOR SPEG TRPC6 CSPG4 TPBG	7.63e-05	173	112	5	36c8338463ee4cc432f568728d55989360f9a68d
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 NLGN1 C5 USP54	7.84e-05	174	112	5	d0e3d15731de6c19c232e3aa492c39d8151cf4ed
ToppCell	facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPOR TRPC6 SSPOP CSPG4 TPBG	8.06e-05	175	112	5	2a53d4f140d5ab096efe8118d8aa351db7838b49
ToppCell	facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPOR TRPC6 SSPOP CSPG4 TPBG	8.06e-05	175	112	5	fb91a45763e4c48d993094a13088ffc19f1e2574
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BNC2 MYLK HLF ACVR2B ZNF503	8.73e-05	178	112	5	0fb36679cddc9ed8f4b5b34e174d5133c2ea1c76
ToppCell	COVID-19-Heart-VSMC\|Heart / Disease (COVID-19 only), tissue and cell type	MYLK SPEG HIPK2 CSPG4 ZFHX3	8.96e-05	179	112	5	a69ad6912b5c10bb9f9d800f724c792341e9bab1
ToppCell	facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK SPEG TRPC6 CSPG4 IGSF9B	9.20e-05	180	112	5	a37cc885fe3f6cb9df69d43358064c83c18412e7
ToppCell	facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK SPEG TRPC6 CSPG4 IGSF9B	9.20e-05	180	112	5	63a6d532b16b8b15c7c9102148d7297ee3afd641
ToppCell	COVID-19-kidney-tDL\|COVID-19 / Disease (COVID-19 only), tissue and cell type	BNC2 UGT3A1 NLGN1 CUBN MLXIPL	9.20e-05	180	112	5	864c895b5eaedefae86f5829fa344f7b686fb59f
ToppCell	Control-Fibroblasts-Airway_smooth_muscle\|Control / group, cell type (main and fine annotations)	MYLK SPEG NLGN1 ZFHX3 IGSF9B	9.20e-05	180	112	5	d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCell	LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 NLGN1 C5 USP54	9.44e-05	181	112	5	0513b9e6673ff7bf8e72ba123ca3794b65d10170
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Lymphocytic-T_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGSH UNC13D SDCBP2 DHX34 NEURL4	9.44e-05	181	112	5	8a8061725e718c89a4c751a415120c5312acc757
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPOR SHROOM3 TRPC6 CSPG4 TPBG	9.69e-05	182	112	5	9edaccf1154cec92ca9a28e9b1f9075cfd422bfd
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 C5 USP54 AKAP1	9.69e-05	182	112	5	1e2149b222a3e9f64841aed45288a6f29394e7b0
ToppCell	LPS_only-Epithelial_alveolar-AT_2-AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 C5 USP54 AKAP1	9.69e-05	182	112	5	d1a1feef318062f25493355d7beee8e5fb0e4206
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA3 UGT3A1 HLF CUBN CDH16	9.69e-05	182	112	5	faf0dfa3adc2d2706b6942b5127093ccdc856447
ToppCell	Control-Epithelial_alveolar-AT_2-AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 NLGN1 C5 USP54	9.69e-05	182	112	5	e97681a4102f3095d5d9e90ad70f1dc46e90983a
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPOR SHROOM3 TRPC6 CSPG4 TPBG	9.69e-05	182	112	5	aba4c06d5d7618ac21b2695bca8e7a1346a91090
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA3 UGT3A1 HLF CUBN CDH16	9.69e-05	182	112	5	be8dd52898525ce6632af0adc2801944f3ac10bd
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 C5 USP54 AKAP1	9.94e-05	183	112	5	5f2db95d44b7de68779de098892892af540fd431
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1-AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 NLGN1 C5 USP54	9.94e-05	183	112	5	06ac66726ec53db810ebb90ec69cfdb903da53f6
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 UNC13D NLGN1 C5	9.94e-05	183	112	5	ff6dde877659cde9daa3263db0932c9c9ef1adac
ToppCell	343B-Lymphocytic-CD4_T-cell-Treg_cell_4\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	SGSH ICAM1 HLF ACVR2B TRIM8	9.94e-05	183	112	5	3cbe0175d05fd39bc430de1ef471ff2c5b56460e
ToppCell	AT1-AT2_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	CAPN9 MYLK SYNPO USP54 RAI2	9.94e-05	183	112	5	6821dca076318115d360ff426eb1218cfe104063
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 UNC13D NLGN1 USP54	1.02e-04	184	112	5	42ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCell	Control-Epithelial_alveolar-AT_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 NLGN1 C5 USP54	1.02e-04	184	112	5	51e129b3fcc2df083eda05a3afe3717218b1e52b
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 NLGN1 C5 USP54	1.02e-04	184	112	5	7cc5796557379c3d1db078c1aeda40659c6e401c
ToppCell	droplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell-pericyte\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPOR SHROOM3 TRPC6 CSPG4 TPBG	1.02e-04	184	112	5	4cb5f299dd7413e0be1ad7af817ee614b23a18ae
ToppCell	droplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPOR SHROOM3 TRPC6 CSPG4 TPBG	1.02e-04	184	112	5	39bb0eb55bdc2cea46e41c7f21d8c5883f14e6bd
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 NLGN1 C5 USP54	1.05e-04	185	112	5	3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b
ToppCell	LPS_only-Epithelial_alveolar-AT_1-AT1-AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 NLGN1 C5 USP54	1.05e-04	185	112	5	68f428e169cfb77de970bdfdeea9b9f16f68d2ba
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 NLGN1 C5 USP54	1.05e-04	185	112	5	0d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 C5 USP54 AKAP1	1.05e-04	185	112	5	fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3
ToppCell	Control-Epithelial_alveolar\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 UNC13D NLGN1 C5 USP54	1.05e-04	185	112	5	3937e026add96a396122139daf8011cfbc60e75c
ToppCell	10x5'-bone_marrow-Hematopoietic_Erythro-Mega-Mega-Mast\|bone_marrow / Manually curated celltypes from each tissue	SEMA6C TRPC6 RADIL RECQL4 CCDC188	1.05e-04	185	112	5	a62ebaff92f2ed27b27b32c27c89cfbe2cb35116
ToppCell	LPS_only-Epithelial_alveolar\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 NLGN1 C5 USP54	1.07e-04	186	112	5	e0a2ea4b46af742bc7c9b2072bb85e27d5c92712
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 NLGN1 C5 USP54	1.07e-04	186	112	5	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SHROOM3 ICAM1 UNC13D MLXIPL USP54	1.10e-04	187	112	5	4ae7465174e0295d2c3b614b321a3b2f514dd22a
ToppCell	LPS-antiTNF-Epithelial_alveolar\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 NLGN1 C5 USP54	1.10e-04	187	112	5	201ff693e4756ee3e44762885b3a303a77eb535b
ToppCell	LPS_only-Epithelial_alveolar-AT_1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 NLGN1 C5 USP54	1.10e-04	187	112	5	ff26a533d310126521efe1d05cf8b9d32e524550
ToppCell	LPS-IL1RA-Epithelial_alveolar\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 NLGN1 C5 USP54	1.13e-04	188	112	5	6164d467b612767ceba15de34176bcc8e8c36ab8
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 NLGN1 C5 USP54	1.13e-04	188	112	5	43a0508d2524a5b310e89e9422843dcaab999bc3
ToppCell	COPD-Stromal-SMC\|Stromal / Disease state, Lineage and Cell class	SPEG HIPK2 SYNPO CSPG4 IGSF9B	1.13e-04	188	112	5	9ffef4b01d0ddd6913c9ed6be79aeaaabd5e41ed
ToppCell	cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	BNC2 SYNPO NCKAP5L DCHS1 ADAMTSL4	1.16e-04	189	112	5	bccb3481ffed597c845fe860da658505316105b5
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 ABCA3 NLGN1 C5 USP54	1.16e-04	189	112	5	5f883ef4cc0383142d538ae61f4fb40dfdb8ef18
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 MYLK SPEG TRPC6 ZFHX3	1.16e-04	189	112	5	7ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell	ASK428-Epithelial-Transformed_epithelium\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	BNC2 SPEG NLGN1 CMYA5 TPBG	1.16e-04	189	112	5	87189275234b5d59484c58acbb14a09903f2b578
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-bronchial_smooth_muscle_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BNC2 SPEG HLF NLGN1 CMYA5	1.16e-04	189	112	5	4dc32b463546bbe7250dddd281b92ad17ec22da1
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-Airway_Smooth_Muscle\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BNC2 SPEG HLF NLGN1 CMYA5	1.16e-04	189	112	5	0d06bf0d7191d13a1c4f30a7881e7ea1093bfd6f
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D231\|Adult / Lineage, Cell type, age group and donor	CAPN9 SHROOM3 ICAM1 UNC13D RADIL	1.16e-04	189	112	5	5a04cb25f8f0447b2cecdb6c3695029281aca26d
ToppCell	droplet-Kidney-nan-21m-Epithelial-kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK SPEG TRPC6 SYNPO ZFHX3	1.19e-04	190	112	5	1803b1e7c36285f9eaabc3c6e9a9752c5908db3d
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	ONECUT2 ZNF503 CHD5 TXNDC16 ZFHX3	1.19e-04	190	112	5	6e92c78799f34b31d098854503c796edb0dc7f80
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPEG TRPC6 CSPG4 ZFHX3 IGSF9B	1.19e-04	190	112	5	73d94fbae92029745989a8712eed8b99fd84c193
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-Stroma____kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK SPEG TRPC6 CSPG4 ZFHX3	1.22e-04	191	112	5	8597a8af294f24496c317d995f07eb5dcc25c13c
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	SAMD8 PER1 MED23 OGA RBM38	1.22e-04	191	112	5	1ecd9849d14d5ebf3daf610e83fb50820cafd3ed
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYLK SPEG THPO CHD5 CSPG4	1.22e-04	191	112	5	d35692c652977500a3c36aa26c347a072b71e441
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYLK SPEG THPO CHD5 CSPG4	1.22e-04	191	112	5	2a107e9096eb58b81b3da61547904d85754f6b2f
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK ICAM1 SYNPO NCKAP5L BRD2	1.22e-04	191	112	5	2f733d510a4862565a817f59829d8387d7ea26d9
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK ICAM1 SYNPO NCKAP5L BRD2	1.22e-04	191	112	5	8691eba35793e4e90f93d50c2145847ee51289f7
ToppCell	droplet-Heart-HEART-1m-Hematologic-red_blood_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA3 GATB BRCA1 RBM38	1.23e-04	101	112	4	6c4524be89cf3eb06769c2963dcded3da1e71ca0
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK SPEG CSPG4 ZFHX3 RBM38	1.25e-04	192	112	5	43228bddca2f606ddcae9731f04c6b1502c4b85a
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK SPEG CSPG4 ZFHX3 RBM38	1.25e-04	192	112	5	f5463c6bcc5c69ac562bec028f7a105c471f2fbe
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYLK SPEG TRPC6 HLF CSPG4	1.25e-04	192	112	5	2cc712186e37fb21a964c032765c36a8b4a852cf
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK SPEG CSPG4 ZFHX3 RBM38	1.25e-04	192	112	5	20fd69eb60b93d22d9be39de44b733db6d761dde
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SHROOM3 NLGN1 CUBN CMYA5 MLXIPL	1.28e-04	193	112	5	82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa
ToppCell	cellseq2-Epithelial-Epithelial_Alveolar-AT2-AT2\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ABCA3 HLF RAD54L2 TTLL4 TRIM8	1.31e-04	194	112	5	df835578d86a49ae5af5632152fbab9548c0a448
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SHROOM3 ZPLD1 UGT3A1 CMYA5 CDH16	1.31e-04	194	112	5	4579b4a44f7c731553a284843c296866027d7c0e
ToppCell	cellseq2-Epithelial-Epithelial_Alveolar\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ABCA3 HLF RAD54L2 TTLL4 TRIM8	1.31e-04	194	112	5	0715f2d55f4a6d2edda1b3dc52f12d25ce59eb10
ToppCell	cellseq2-Epithelial-Epithelial_Alveolar-AT2\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ABCA3 HLF RAD54L2 TTLL4 TRIM8	1.31e-04	194	112	5	a4f7cd507eba40985d82635bbae28c7f5703f883
Drug	Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A	CTC1 ICAM1 HIPK2 WNK1 FASTK HELZ OGA DHX34	4.09e-06	194	108	8	5641_DN
Drug	aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A	EPOR ICAM1 PER1 HIPK2 GTF3C5 NF1 HELZ OGA	4.58e-06	197	108	8	5201_DN
Disease	Malignant neoplasm of breast	EPOR NPBWR1 ABCA3 CATSPERE HDAC4 PER1 CUBN TRAPPC8 WNK1 PKDREJ CIC NF1 BRCA1 CHD5 USP54	8.76e-06	1074	108	15	C0006142
Disease	pulmonary hypertension (is_marker_for)	HDAC4 ICAM1 TRPC6 THPO	9.11e-05	64	108	4	DOID:6432 (is_marker_for)
Disease	Acute monocytic leukemia	CTC1 FANCL BRCA1	1.17e-04	26	108	3	C0023465
Disease	bitter alcoholic beverage consumption measurement	CIC MLXIPL NF1 ZFHX3 IGSF9B	1.33e-04	133	108	5	EFO_0010092
Disease	Miller Dieker syndrome	CTC1 FANCL BRCA1	1.63e-04	29	108	3	C0265219
Disease	nonsyndromic deafness (implicated_via_orthology)	ALG10 PPIP5K2	1.97e-04	6	108	2	DOID:0050563 (implicated_via_orthology)
Disease	Focal Segmental Glomerulosclerosis, Not Otherwise Specified	TRPC6 SYNPO	4.70e-04	9	108	2	C4049702
Disease	MENTAL RETARDATION, AUTOSOMAL DOMINANT 40	BRCA1 DHX34	4.70e-04	9	108	2	C4225275
Disease	proteinuria (biomarker_via_orthology)	ICAM1 TRPC6	5.86e-04	10	108	2	DOID:576 (biomarker_via_orthology)
Disease	Gastric Adenocarcinoma	SPEG TEX14 BRD2	6.05e-04	45	108	3	C0278701
Disease	level of Diacylglycerol (18:1_18:1) in blood serum	MLXIPL B4GALNT2	7.14e-04	11	108	2	OBA_2045170
Disease	retinopathy of prematurity (biomarker_via_orthology)	EPOR ICAM1	8.55e-04	12	108	2	DOID:13025 (biomarker_via_orthology)
Disease	Colorectal Carcinoma	ABCA3 PER1 CUBN WNK1 NF1 CHD5 DCHS1 B4GALNT2 SDCBP2	1.12e-03	702	108	9	C0009402
Disease	Intellectual Disability	HDAC4 MED13L CIC NF1 BRCA1 TRIM8 MED23	1.31e-03	447	108	7	C3714756
Disease	Situs ambiguus	SHROOM3 ACVR2B	1.35e-03	15	108	2	C0266642
Disease	brain edema (biomarker_via_orthology)	ICAM1 C5	1.35e-03	15	108	2	DOID:4724 (biomarker_via_orthology)
Disease	monocyte percentage of leukocytes	SEMA6C MED13L WNK1 MLXIPL NF1 BRCA1 RBM27 B4GALNT2 NEURL4	1.48e-03	731	108	9	EFO_0007989
Disease	Profound Mental Retardation	HDAC4 MED13L CIC NF1	1.73e-03	139	108	4	C0020796
Disease	Mental Retardation, Psychosocial	HDAC4 MED13L CIC NF1	1.73e-03	139	108	4	C0025363
Disease	Mental deficiency	HDAC4 MED13L CIC NF1	1.73e-03	139	108	4	C0917816
Disease	MYELODYSPLASTIC SYNDROME	CTC1 FANCL BRCA1	1.93e-03	67	108	3	C3463824
Disease	visceral adipose tissue measurement	BNC2 NLGN1 POM121C WNK1 TRIP12 HELZ SIGLEC1	1.99e-03	481	108	7	EFO_0004765
Disease	freckles	BNC2 AKAP1	2.42e-03	20	108	2	EFO_0003963
Disease	Sarcoma	CIC NF1	2.66e-03	21	108	2	C1261473
Disease	unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement	C6orf89 ZPLD1 SDCBP2	2.76e-03	76	108	3	EFO_0003761, EFO_0008343, MONDO_0004985, MONDO_0005090
Disease	Acute Lung Injury	MYLK ICAM1	2.92e-03	22	108	2	C0242488
Disease	reaction time measurement	BNC2 C6orf89 HLF GATB MED13L MLXIPL TXNDC16 ZFHX3	2.93e-03	658	108	8	EFO_0008393
Disease	lung non-small cell carcinoma (is_marker_for)	ICAM1 NF1 BRCA1 ZFHX3	3.51e-03	169	108	4	DOID:3908 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
TNIYAPPLPSLALPS	AKAP1	681	Q92667
YSLVAPAFPQPPALV	CELF3	336	Q5SZQ8
LPPAEPLGNVPFLLY	ASCL5	106	Q7RTU5
QYVISSPPPILENPT	ADAMTSL4	596	Q6UY14
TFPLLTIPEIPGYLP	CATSPERE	216	Q5SY80
LTISPGPVTPIPVLY	CTC1	191	Q2NKJ3
APPLLRVSGPYFPTL	CSPG4	1376	Q6UVK1
PYLFPVAAVEAPVLP	CHD5	996	Q8TDI0
PLLVQPNLPFGYPVH	B4GALNT2	186	Q8NHY0
QYINPVSAPLLGLPP	BNC2	326	Q6ZN30
VQPVPPFYRSLLTPG	BNC2	566	Q6ZN30
PYPPFIADPFLVAIQ	ABCA3	246	Q99758
PNLPPLVLYDATSLP	GATB	341	O75879
PGILPSYSLPFSQPL	RAD54L2	1376	Q9Y4B4
LPLAYPPPQFAHALL	ANKRD17	1881	O75179
PPATLLVPYPVIVPL	RAI2	226	Q9Y5P3
RLPPPLPQNLLYTVS	RBM27	411	Q9P2N5
YPPAIVQPSVVIPAA	RBM38	146	Q9H0Z9
VIPAAPVPSLSSPYI	RBM38	156	Q9H0Z9
VTFDTLLAGPPYPPL	RIMBP3B	1076	A6NNM3
VTFDTLLAGPPYPPL	RIMBP3C	1076	A6NJZ7
VLESYENPPPIVLPS	RADIL	766	Q96JH8
AVLPVRTQDPFLPYP	FASTK	441	Q14296
VPGTPTPPIFEQLQY	DCHS1	781	Q96JQ0
YLLPVAPSKPTAPIF	MYLK	611	Q15746
LPVPNPSLPYEQTIV	HIPK2	71	Q9H2X6
APLPLYTSPSLPNIT	HDAC4	341	P56524
SPIQLYSPPFILAPI	MED13L	1791	Q71F56
VQPNSIPSAIYPAPV	FAM168A	171	Q92567
PSPLQVPTYPQLTLE	NCKAP5L	576	Q9HCH0
VPTYPQLTLEVPQAP	NCKAP5L	581	Q9HCH0
LPYAVPPNFLPSPLL	ATXN1L	146	P0C7T5
LVLPNYLFPTPSSYP	PER1	921	O15534
LYLLPPGAPFIELLP	GHDC	311	Q8N2G8
VDPPVQIQSPYLPIY	MED23	941	Q9ULK4
NTYTTLTPLQPLPPI	ONECUT2	146	O95948
NPTFIPPPYGVLRSL	HLF	11	Q16534
PVIQFLGVPYAAPPT	NLGN1	76	Q8N2Q7
FPILAPAVGSYLPPT	PARP4	1316	Q9UKK3
PLAIQLPPVLIIGPY	HELZ	656	P42694
LTLPPPPQLGYSITA	POM121C	496	A8CG34
EQLTLPPPPQLGYSI	POM121B	101	A6NF01
LPTSTLQYQPPAPAL	POU2AF1	186	Q16633
NPYRIPPLFPIKSFV	BRCA1	976	P38398
PSKPTLPLVIPYSQV	CUBN	2651	O60494
LPSPLPQEFTYLNSP	FCRL1	346	Q96LA6
QRLPPYPYSSPSLVL	CRTC2	481	Q53ET0
LIFSATLAYFPPRPP	SLC49A4	241	Q96SL1
YVVNPTPFEGLVPPL	CCDC188	361	H7C350
LVATPLFLKPGIPYP	C5	356	P01031
ETPPYLLSPVKPQTL	CMYA5	2806	Q8N3K9
PIPYGFLPQNILPLA	CSN2	71	P05814
QVVYTTLPAPPAQAP	ATF7IP	1061	Q6VMQ6
NSLIPAAEPLPPSYV	EPOR	491	P19235
PYQLQTFVLPATPPQ	ICAM1	206	P05362
YFVIQPFSPLAPEPV	C6orf89	76	Q6UWU4
LPPGEYILIPSTFEP	CAPN9	461	O14815
IEPPPPASLETAILY	DHX34	546	Q14147
EQPPPVLLSPSLQYA	NEURL4	1471	Q96JN8
PAPALTLAPVPSQYL	CDH16	661	O75309
PLPAPLAVAVPVVYA	NPBWR1	31	P48145
VIALTYTVLPPFLNP	OR14I1	271	A6ND48
DTPVELLAPLPPYFS	RPUSD3	326	Q6P087
QSLPYVFIPPDIQTP	RHNO1	146	Q9BSD3
LPVPYAAFPPLISSD	RNF38	256	Q9H0F5
PPSLNYIPPVLQLSG	TEX14	796	Q8IWB6
PSPQIRFPLATYILP	SSPOP	2046	A2VEC9
QTYPPLPDIFLDSVP	SAMD8	181	Q96LT4
LYALPPPPQFYSSLI	FANCL	101	Q9NW38
LFFQPPPLTPTSKVY	OGA	701	O60502
VTFDTLLAGPPYPPL	RIMBP3	1076	Q9UFD9
PEVPSLDPTVLPLYS	RECQL4	441	O94761
QPPYQLRPSLFVLSP	SYNPO	806	Q8N3V7
LYLGPQSTVPPSFLP	PKDREJ	621	Q9NTG1
AQPGQPLLPTSIYPV	SHROOM3	456	Q8TF72
PIPFFLAIYLPISNP	OPRPN	126	Q99935
APTPFPIELLPLGYS	MLXIPL	466	Q9NP71
DPLDVLVPYFVPNTP	SGSH	216	P51688
AISPPPVLYPNLAEL	SDCBP2	36	Q9H190
LYTPPPEIPTTVLNI	BRD2	226	P25440
PYVIYRLNIPLPPTS	ALG10	421	Q5BKT4
YEPPPTAPTLLTVLA	ACVR2B	126	Q13705
APLAQPSQAPPSLVY	CIC	1106	Q96RK0
VSLSAPPPPYSEVIL	TMEM92	111	Q6UXU6
QEPAVVLQPLYPPSL	TULP4	1221	Q9NRJ4
GLPSPLSYVPVFPSL	UGT3A1	176	Q6NUS8
YFDPLPPLPLLVLVN	TXNDC16	681	Q9P2K2
TPDPPTIISYLPGLL	ZPLD1	136	Q8TCW7
PPQALQTLALPLTPY	SPEG	2231	Q15772
IFIAPGNLSLPIPIY	ERVFRD-1	326	P60508
PPTSLQVPAAYPGIL	IGSF9B	1081	Q9UPX0
LTPTSPYPPALQSQL	NF1	2756	P21359
TPQLYTTFLPPPEGV	SEMA6C	676	Q9H3T2
PSSPAVLTVLYPPRQ	SIGLEC1	586	Q9BZZ2
EYLQPLPSTPVSPIE	ZNF503	91	Q96F45
PLPQLPLPYINSSAT	TRAPPC8	661	Q9Y2L5
PILPPSLQTSYVFLG	TPBG	346	Q13641
LYIPPPIFSRLDAPV	GTF3C5	166	Q9Y5Q8
LFTTSPLLLQYIPRP	TRIM49B	391	A6NDI0
PVPFNLVPSPKSLFY	TRPC6	761	Q9Y210
LNTYTPAKILPTPPA	PPIP5K2	1181	O43314
LPTPLLPQYPVSQIP	WNK1	831	Q9H4A3
LYSLNPSLPTPQPVR	WDR3	391	Q9UNX4
PFSTPVPFLQSVPLY	TRIM8	351	Q9BZR9
VSNPLEVYLIPTPPE	TRIP12	1446	Q14669
VRPALIYSLFPNVPP	TTLL4	571	Q14679
PLLYPPFPQVPVVLQ	PRRT1B	116	A0A1B0GWB2
EVPQTRLPLTYPAPN	UNC13D	1036	Q70J99
NPPVLAPTSTAFPYL	VPS37A	126	Q8NEZ2
LPPILAPQAYLNFAP	nan	61	Q6ZTC4
APQAYLNFAPPTLVP	nan	66	Q6ZTC4
LPTAYPALQGIPPVL	ZFHX3	3111	Q15911
PQLYLPQPQFLSPDV	USP54	1471	Q70EL1
TGQYTLFPLPPTLPT	THPO	301	P40225
PLTPYLPAVPSSFRV	NAALADL1	256	Q9UQQ1
AAPYVVSPSVPIPLL	NACC2	156	Q96BF6
VDLLVFNPPYVVTPP	N6AMT1	116	Q9Y5N5